{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:52:46Z","timestamp":1790056366741,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010609","name":"Gda\u0144ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["ST49"],"award-info":[{"award-number":["ST49"]}],"id":[{"id":"10.13039\/501100010609","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.trim.2025.102274","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:12:35Z","timestamp":1754439155000},"page":"102274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The KIR\/HLA class I co-expression and transplantation outcomes after HSCT\/BMT from HLA-matched sibling donors"],"prefix":"10.1016","volume":"92","author":[{"given":"Joanna","family":"D\u0119bska-Zielkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"S\u0142omi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dukat-Mazurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gra\u017cyna","family":"Moszkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bieniaszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Maciej","family":"Zaucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Trzonkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Zieli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2025.102274_bb0005","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1182\/hematology.2024000588","article-title":"Biology of post-transplant relapse: actionable features","volume":"2024","author":"Orofino","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.trim.2025.102274_bb0010","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1182\/blood-2021-146696","article-title":"Outcomes with natural killer cells infusion after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"138","author":"Mushtaq","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.trim.2025.102274_bb0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fimmu.2017.00465","article-title":"Natural killer cells in graft-versus-host-disease after allogeneic hematopoietic cell transplantation","volume":"8","author":"Simonetta","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0020","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.1182\/bloodadvances.2019000242","article-title":"Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation","volume":"3","author":"Zhao","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2025.102274_bb0025","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1182\/blood-2013-11-540625","article-title":"The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia","volume":"123","author":"de Smith","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.trim.2025.102274_bb0030","article-title":"Influence of the immunogenetic KIR and HLA systems on long-term renal transplant outcome","author":"La Manna","year":"2013","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.trim.2025.102274_bb0035","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-like receptors (KIRs): their role in nk cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0040","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0045","doi-asserted-by":"crossref","first-page":"230","DOI":"10.20517\/jtgg.2023.25","article-title":"Targeting KIR as a novel approach to improve CAR-NK cell function","volume":"7","author":"Graham","year":"2023","journal-title":"J. Transl. Genet. Genomics"},{"key":"10.1016\/j.trim.2025.102274_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585731","article-title":"A detailed view of KIR haplotype structures and gene families as provided by a new motif-based multiple sequence alignment","volume":"11","author":"Roe","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26073242","article-title":"The role of killer Ig-like receptors in diseases from a to Z","volume":"26","author":"Agnello","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2025.102274_bb0060","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","article-title":"Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations","volume":"132","author":"Campbell","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.trim.2025.102274_bb0065","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3389\/fimmu.2017.00810","article-title":"Patients lacking a KIR-ligand of HLA group C1 or C2 have a better outcome after umbilical cord blood transplantation","volume":"8","author":"Mart\u00ednez-Losada","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107361","article-title":"The role of KIR positive NK cells in diseases and its importance in clinical intervention","volume":"92","author":"Dizaji Asl","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.trim.2025.102274_bb0075","first-page":"800","article-title":"Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules","volume":"367","author":"Parham","year":"2012"},{"key":"10.1016\/j.trim.2025.102274_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3389\/fimmu.2017.00041","article-title":"Reduction of relapse after unrelated donor stem cell transplantation by KIR-based graft selection","volume":"8","author":"Heidenreich","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0085","doi-asserted-by":"crossref","DOI":"10.1111\/tan.13327","article-title":"Activating KIR haplotype influences clinical outcome following HLA-matched sibling hematopoietic stem cell transplantation","author":"Heatley","year":"2018","journal-title":"HLA"},{"key":"10.1016\/j.trim.2025.102274_bb0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.beha.2016.10.010","article-title":"How important is NK alloreactivity and KIR in allogeneic transplantation?","volume":"29","author":"Shaffer","year":"2016","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.trim.2025.102274_bb0095","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1182\/blood.2019001212","article-title":"Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP\/CIBMTR","volume":"134","author":"Dehn","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.trim.2025.102274_bb0100","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1182\/bloodadvances.2019001053","article-title":"KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation","volume":"4","author":"Weisdorf","year":"2020","journal-title":"Blood Adv."},{"key":"10.1016\/j.trim.2025.102274_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00251-019-01153-6","article-title":"Study of KIR gene expression at the mRNA level in specific donor-derived NK cells after allogeneic HSCT","volume":"72","author":"Li","year":"2020","journal-title":"Immunogenetics"},{"key":"10.1016\/j.trim.2025.102274_bb0110","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting-Airlie house, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.trim.2025.102274_bb0115","first-page":"91","article-title":"New criteria of diagnosis and staging of chronic graft versus host disease\u2014report from Transplantation Workshop Warsaw 2006","volume":"38","author":"Zaucha","year":"2007","journal-title":"Acta Haematol. Pol."},{"key":"10.1016\/j.trim.2025.102274_bb0120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868175","article-title":"KIR-ligand interactions in hypertensive disorders in pregnancy","volume":"13","author":"Stefa\u0144ska","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0125","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.humimm.2020.03.004","article-title":"Impact of donor KIRs and recipient KIR\/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT","volume":"81","author":"Mansouri","year":"2020","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0130","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/sj.leu.2403525","article-title":"Identification of natural killer cell receptor phenotypes associated with leukemia","volume":"18","author":"Verheyden","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.trim.2025.102274_bb0135","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.humimm.2014.04.004","article-title":"Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma","volume":"75","author":"Vejbaesya","year":"2014","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0140","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood-2012-07-440495","article-title":"Lack of association between KIR genes and acute lymphoblastic leukemia in children","volume":"120","author":"Babor","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.trim.2025.102274_bb0145","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbmt.2016.12.638","article-title":"Donor killer immunoglobulin-like receptor haplotype B\/x induces severe acute graft-versus-host disease in the presence of human leukocyte antigen mismatch in T cell-replete hematopoietic cell transplantation","volume":"23","author":"Hosokai","year":"2017","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc."},{"key":"10.1016\/j.trim.2025.102274_bb0150","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.transproceed.2017.09.070","article-title":"Donor selection based on killer cell immunoglobulin\u2013like receptor (KIR) genotype may improve outcome after T-cell\u2013replete haploidentical transplantation","volume":"50","author":"Tor\u00edo","year":"2018","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.trim.2025.102274_bb0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.humimm.2007.01.019","article-title":"Donor-recipient combinations of group a and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation","volume":"68","author":"McQueen","year":"2007","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0160","article-title":"Haplotype motif-based models for KIR-genotype informed selection of hematopoietic cell donors fail to predict outcome of patients with myelodysplastic syndromes or secondary acute myeloid leukemia","volume":"11","author":"Schetelig","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2025.102274_bb0165","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.bbmt.2018.08.009","article-title":"Donor KIR genotype impacts on clinical outcome after T cell-depleted HLA matched related allogeneic transplantation for high-risk pediatric leukemia patients","volume":"24","author":"Escudero","year":"2018","journal-title":"Biol. Blood Marrow Transplant. J. Am. Soc."},{"key":"10.1016\/j.trim.2025.102274_bb0170","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2016-05-713099","article-title":"KIR gene haplotype: an independent predictor of clinical outcome in MDS patients","volume":"128","author":"Stringaris","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.trim.2025.102274_bb0175","doi-asserted-by":"crossref","DOI":"10.1111\/tan.15364","article-title":"Molecular relapse monitoring reveals the domination of impaired NK cell education over impaired inhibition in missing KIR-ligand recognition in patients after unrelated hematopoietic stem cell transplantation for malignant diseases","volume":"103","author":"Nowak","year":"2024","journal-title":"HLA"},{"key":"10.1016\/j.trim.2025.102274_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158242","article-title":"Donor-recipient matching for KIR genotypes reduces chronic GVHD and missing inhibitory KIR ligands protect against relapse after myeloablative, HLA matched hematopoietic cell transplantation","volume":"11","author":"Faridi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.trim.2025.102274_bb0185","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/tan.12829","article-title":"The effect of missing KIR ligands, activating KIR genotype and haplotype on the outcome of T-cell-replete hematopoietic stem cell transplantation from HLA-identical siblings in Thai patients","volume":"87","author":"Khanuntong","year":"2016","journal-title":"HLA"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327425001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T23:54:10Z","timestamp":1757116450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327425001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":37,"alternative-id":["S0966327425001029"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2025.102274","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The KIR\/HLA class I co-expression and transplantation outcomes after HSCT\/BMT from HLA-matched sibling donors","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2025.102274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102274"}}